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A 45-year-old female developed hypertension and hypokalemia. Elevated plasma aldoste-
rone and suppressed plasma renin levels were measured with no evidence for glucocorticoid or
androgen abnormalities. A left adrenal tumor was removed that showed histologic criteria for
malignancy. It is commonly taught that malignant adrenal tumors arerecognized by their mul-
tiple hormone production. However, isolated aldosterone production by a carcinoma can
occur and requires close follow-up observation and therapy for this highly malignant tumor.
In 1955, Conn et al. described the syndrome of primary hyperaldosteronism [1]
and one year later reported a patient with an aldosterone-producing adrenal cortical
adenoma producing primary hyperaldosteronism, which has come to be known as
"Conn syndrome" [2]. Adrenal adenomas account for approximately 70 percent,
bilateral adrenal hyperplasia for 25 to 30 percent, and adrenal carcinoma for less
than 5 percent ofall cases ofConn's syndrome [3]. The first such carcinoma was re-
ported in 1955 by Foye and Feichtmeir [4], just after Conn's original report. Adrenal
cortical carcinoma is of itself very rare and in a review of one hundred and thirty-
eight such cases by Hutter et al. in 1966 [5], none had overproduction ofaldosterone
or evidence for hypermineralocorticoidism.
Secreting adrenal carcinomas predominantly produce glucocorticoids or their
precursors rather than mineralocorticoids. In those adrenal carcinomas that do pro-
duce aldosterone, other steroid hormones are also produced in excess [3,6,7,27].
These multihormone-producing carcinomas do not fit the rigid criteria which Conn
[2] proposed specifically to exclude tumors associated with clinical or chemical evi-
dence of androgen or glucocorticoid overproduction. Therefore, even the first case
by Foye and Feichtmeir [4] does not fulfill Conn's criteria because of chemical evi-
dence of excess glucocorticoid secretion.
Mineralocorticoid excess as the only biochemical evidence of excessive hormone
secretion by an adrenocortical carcinoma is distinctly uncommon [3]. Thus, a pa-
tient who presents with hyperaldosteronism and who has no evidence for other
steroid abnormalities most likely has a benign adrenal tumor.
This paper reports a patient and reviews the previously published literature of
isolated aldosterone hypersecretion due to a malignant adrenal carcinoma.
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A 45-year-old white female noted paresthesias, carpal-pedal spasm, and muscle
weakness for several months. The new onset ofhypertension was noted with a blood
pressure of 220/120 in both arms, without orthostatic change. Her blood pressure
had been normal one year earlier at her last examination. Her only medication was
occasional acetaminophen. She was 63 inches tall and weighed 115 pounds. She had
normal body hair, fat distribution, and pigmentation. There were no striae, buffalo
hump, moon facies, or peripheral edema. She had a normal female habitus and in-
ternal pelvic exam. There were no signs of virilization. Fundoscopic examination
was normal. Neurologic examination, including visual fields, was within normal
limits.
She had had three full-term pregnancies and three spontaneous abortions. There
was no history of hypertension during any of her pregnancies. She developed tran-
sient hypothyroidism after her last pregnancy and had been on replacement therapy
until three years ago. Since that time she has required no therapy. She had had a
transabdominal hysterectomy with aright salpingo-oophorectomy for dysfunctional
uterine bleeding at age thirty-four. An incidental appendectomy was also done at
that time.
Her brother and father have chronic hypertension and her mother had ahistory of
"thyroid disease" and died at age 53 of a ruptured aortic aneurysm. There was no
family history of adrenal disease, kidney stone, diabetes, or pituitary dysfunction.
Laboratory Data
Initial laboratory evaluation revealed a fasting glucose of92 mg %, hematocrit of
41 percent, white blood count of 5,000 with a normal differential, serum sodium
151 mEq/L, potassium 1.7 mEq/L, chloride 104 mEq/L, bicarbonate 32 mEq/L,
calcium 9.2 mg/dl, phosphate 3.4 mg/dl, and creatinine of 1.0 mg/dl. Other labora-
tory values included a normal "spot urine" for 5-HIAA and normal thyroid function
studies. EKG revealed tall U waves, but otherwise was normal. Hormone levels are
listed in Table 1.
Clinical Course
A presumptive diagnosis of primary aldosteronism was made and she was placed
on amiloride, 5 mg twice a day, but her serum potassium concentration remained
low. On spironolactone, 100 mg three times daily, plus 80 mEq ofKCL, three times
daily, her blood pressure and serum electrolytes normalized. A computerized axial
tomogram revealed a 3.2 cm left adrenal mass (Fig. 1). The right adrenal was nor-
mal. The patient was admitted to the Hospital of St. Raphael for surgery.
One day pre-operatively the spironolactone and potassium were stopped in antici-
pation of post-operative hyperkalemia [11]. At surgery, a left adrenalectomy was
performed via a left flank incision. The adrenal gland weighed 20 grams and did not
have the yellowish color typical of a benign adrenal adenoma (Fig. 2). Histologic
examination revealed vascular (Fig. 3) and capsular invasion (Fig. 4) and many
atypical mitotic figures (Fig. 5); a diagnosis of an adrenal cortical carcinoma was
made. The non-involved adrenal was normal in appearance and was not atrophic.
Post-operatively, potassium supplementation was needed for five days as she re-
mained somewhat hypokalemic (2.9 mEq/L). Her 24-hour urine potassium excre-
tion was 22 mEq K+/24 hours and her blood pressure corrected without therapy. A
liver-spleen scan and chest X-ray were normal with no evidence ofmetastatic disease.
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FIG. 1. Computerized
axial tomography showing
a 3.2 cm left adrenal tumor
(arrow).
FIG. 2. Twenty-gram left
adrenal gland.
FIG. 3. Malignant cells
within adrenal vein (arrow).
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FIG. 4. Invasion of
adrenal capsule by tumor
cells (arrow).
DISCUSSION
Benign adrenal adenomas usually have a homogeneous golden-yellow color and
weigh less than six grams [12]. Adrenal cortical carcinomas have soft, friable nodu-
lar areas, frequently have areas ofnecrosis and hemorrhage, and can weigh as much
as 2,000 grams [12].
Microscopically it usually is difficult to distinguish benign from malignant tum-
ors, but a number of criteria have been used to distinguish adenoma from carci-
noma [3,13,14,15]. Theseinclude: (1) capsular invasion, (2) vascular invasion, which
may cause vessel occlusion and thrombosis, (3) presence of mitoses, (4) presence of
bizarre giant cells (large cells with abundant acidophilic cytoplasm and bizarre hy-
perchromatic nuclei and multinucleated forms), and (5) presence of spindling of
tumor cells.
These features may be absent in malignant adrenal tumors or may be present in
some benign tumors. Hence, the only reliable and universally accepted criterion of
malignancy is the presence of metastases [12].
FIG. 5. Atypical mitotic
figure (arrow).Adrenal cortical cancers of all types are highly malignant. They frequently recur,
even after presumed total excision, with metastases found in the liver (60 percent),
regional lymph nodes (40 percent), and lungs (40 percent) [14]. One-half of the 38
patients in the series of Lipsett et al. [7] were dead after two years, and in the study
by Huvos et al. [14] 30 of 34 patients were dead within three years.
Occasionally, adrenal cortical carcinomas produce hypoglycemia, polycythemia,
or the syndrome of inappropriate antidiuretic hormone [7] (none of which was pres-
ent in our patient). The degree ofhypokalemia and the urinary aldosterone excretion
rate tend to be greater in patients with malignant tumors [3] but an individual pa-
tient cannot clearly be categorized as having a benign lesion or a malignancy on
these criteria alone. Likewise, a good response to spironolactone does not preclude a
malignant lesion as the cause of the hypermineralocorticism.
It is widely accepted clinical teaching that an adrenal carcinoma does not produce
only aldosterone and that hyperaldosteronism due to a carcinoma can be suspected
pre-operatively by chemical or clinical evidence of androgen and/or glucocorticoid
excess [27]. Although the majority of aldosterone-producing adrenal carcinomas fit
such a description, there are only seven cases of adrenal carcinoma, in addition to
our patient, which solely produced aldosterone [3,8,9,10,26].
In a series of 105 patients presenting with primary aldosteronism, Salassa et al. [3]
reported six patients with large adrenocortical tumors. Four of these tumors had
histological features ofmalignancy while two had "benign" histology. These last two
patients had isolated aldosterone overproduction as their only abnormality and
have survived for more than nine years. The four malignant tumors ranged in size
from 250 to 1,050 grams and three of the four had serum potassium levels less than
2.5 mEq/L. Each had an elevated 24-hour urinary aldosterone and normal 24-hour
urinary 17-ketosteroids. One of the four, however, had an elevated 24-hour urinary
17-ketogenic steroid level and elevated tetrahydro-1 1-deoxycortisol. Thus only three
patients of this series had a malignant adrenal tumor producing only aldosterone.
Our patient, one of Salassa's cases for whom data is given (his case number 5),
and four other cases ofisolated hyperaldosteronism due to malignant adrenal tumor
are summarized in Table 2. Five were females, one was male. All had similar labora-
tory abnormalities: profound hypokalemia, hypernatremia, elevated plasma or uri-
nary aldosterone, suppressed renin activity, and normal 17-hydroxy and 17-keto-
steroids. However, very little hormone data is available in the report of Santander
et al. [10]. The urinary K+ loss was profound in our patient yet within normal limits
in Revach et al.'s case [9] although her urinary K+ was inappropriately high in relation
to her serum K+ of 2.4 [16]. Of interest is the normal blood pressure in Shah et al.'s
patient [8]. Greathouse et al. report the most hormonal data for their case [26].
Santander et al. [10] were unable to measure urinary aldosterone or plasma renin
activity, as these were unavailable to them in their country (Venezuela). This case
assumes a diagnosis of an adrenal cortical carcinoma secreting only mineralocorti-
coids. Whether it secreted aldosterone or a different mineralocorticoid [17] or even
had hypertension and hypokalemia on a non-adrenal basis is unproven.
There have been a number of cases of malignant adrenal carcinoma which clin-
icallypresented as isolatedhypermineralocorticoidism [4,10,18,19,20,21,22,23], i.e.,
arterial hypertension and hypokalemic metabolic alkalosis without clinical but with
laboratory evidence of hypercortisolism or hyperandrogenism. Most of these cases
have been reviewed by Alterman et al. [18], who presented an additional case with a
mixed hormonal output. In this same article they reviewed ten other cases. Nine had
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a mixed secretory pattern and only one had normal 24-hour urinary 17-hydroxy and
17-ketosteroids (the case of Santander et al. [10]). Other cases of adrenal cortical
carcinoma secreting multiple hormones have been reported [24,25].
The demonstration of excessive production of multiple hormones by an adrenal
tumor is important since it suggests the presence of a malignant carcinoma. How-
ever, our case plus sixothers reported intheliterature [3,8,9,10,26] demonstrate that
isolated aldosterone can rarely be produced by an adrenal cortical carcinoma. Fail-
ure to recognize this association may lead to an erroneous diagnosis of a benign
adrenal adenoma and delay operative intervention and proper follow-up. If one
waits for the presence of metastases to establish the diagnosis of malignant adrenal
cortical carcinoma, the chance of curative surgery may be lost.
Our patient's tumor fulfilled most ofthe histologic criteria for carcinoma [12,13,
14,15] and consequently she will require lifelong supervision for recurrence ofdisease.
Our patient as well as the other reported cases [3,8,9,10,26] indicate that isolated
hyperaldosteronism may be caused by a malignant adrenal cortical carcinoma.
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